Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

The Melanoma Research Foundation Launches 2023 Miles for Melanoma 5k Program in Washington, DC


The Melanoma Research Foundation (MRF) is proud to announce the return of their Washington, DC Miles for Melanoma 5K event, held Saturday, May 6th, at Yards Park, 7:30AM ET.

The annual 5K event tours the country to celebrate local melanoma patients, thrivers and caregivers. This year, the melanoma community will unite to raise $100,000 in support of critical melanoma research.

In addition to raising critical research funds, this event helps elevate public awareness around early detection and prevention of cutaneous melanoma and rare melanoma subtypes including pediatric/AYA, mucosal and ocular melanoma. The Miles for Melanoma program also highlights the importance of sun safety and scheduling annual dermatological skin checks. Local presenting sponsor, INOVA Schar Cancer Institute, will provide complimentary on-site skin checks to all registered participants on event day.

The MRF welcomes a wide range of local presenting and national sponsors to the event including; INOVA Schar Cancer Institute, Castle Biosciences, Champion Title, Metro Mohs Surgery Center and Capital Laser & Skin Care. National sponsors include National Grassroots Sponsor, Bristol Myers Squibb, National Courage Sponsor, Pfizer, National Prevention Sponsor, Neutrogena and National Apparel Partner, Cabana Life.

Register to attend the DC Miles for Melanoma 5K event here, by Wednesday, May 3rd at 11:59PM ET. On-site registration will also be available on event day.

About the Melanoma Research Foundation (MRF):

The Melanoma Research Foundation (MRF) is the largest independent organization devoted to melanoma. Committed to the support of medical research in finding effective treatments and eventually a cure for melanoma, the MRF also educates patients and physicians about prevention, diagnosis and the treatment of melanoma. The MRF is a committed advocate for the melanoma community, helping to raise awareness of this disease and the need for a cure. The MRF’s website (http://www.melanoma.org) is the premier source for melanoma information seekers. Find the MRF on Facebook, Twitter, Instagram and TikTok.

Media Contact

Nicole Nishanian

Miles for Melanoma Development Officer

NNishanian@melanoma.org

Share article on social media or email:



DecisionHealth offers a suite of solutions, training, and resources to help home health agencies navigate OASIS-E changes in 2023 and beyond


“The OASIS-E changes are some of the biggest to hit the home health industry, and they’ve placed an additional burden on home health staff who were already feeling the crunch.”

With the release of OASIS-E, the latest version of the home health data set, CMS has introduced 27 new items and has removed older questions and replaced them with either one or more related questions. Home health agencies report they are spending an average of 25 extra minutes per OASIS assessment thanks to the sweeping changes. DecisionHealth offers a suite of solutions to help agencies adapt, minimize negative productivity impacts, and enable staff to answer OASIS-E items more efficiently and accurately to drive Home Health Value-Based Purchasing (HHVBP) payments in the future.

“The OASIS-E changes are some of the biggest to hit the home health industry, and they’ve placed an additional burden on home health staff who were already feeling the crunch,” says Marci Geipe, senior content and product manager at DecisionHealth.

Home health professionals can choose from a variety of virtual, in-person, or on-demand training to create a program that best fits the unique needs of their clinicians, coders, and quality managers.

  • Ultimate Coding & OASIS Training Virtual Series offers beginner, intermediate, and advanced programs, plus a course dedicated to OASIS-E changes.
  • Home Health Coding Summit from August 14–16, 2023, offers a Coding, OASIS, and Documentation QA Boot Camp that allows coders and reviewers to ensure OASIS-E answers are supported by proper codes and documentation. It also offers Intermediate and Advanced Coding tracks and a first look at fiscal year (FY) 2024 code, guideline, and OASIS changes.
  • OASIS-E Guidance Paves Path to Better Outcomes—On-Demand Webinar with expert Brandi Whitemyer, RN, CDIP, COS-C, HCS-D, reviews the new OASIS-E guidance and provides practical knowledge on how to use it in documentation.

Once clinicians and QA teams are trained, DecisionHealth also provides a tool that will allow them to quickly look up OASIS-E items and their related guidance so they can make the most informed and accurate decisions. Home Health Coding Center, a cloud-based decision-support tool, offers access to CMS official OASIS-E guidance and DecisionHealth’s exclusive expert tips paired with ICD-10 code lookup in a handy online workflow tool.

Plus, a wide range of additional OASIS resources are available at store.decisionhealth.com, including a Home Care Clinical Specialist—OASIS (HCS-O) Certification for home health professionals who are serious about validating their OASIS proficiency.

“The information and resources that DecisionHealth offers will ease the burden on key staff by making sure they are comfortable with the OASIS-E changes and the entire OASIS assessment to minimize productivity impacts, get clinician buy-in and secure future HHVBP payments that are based on outcome scores,” Geipe adds.

DecisionHealth is continuously rolling out new solutions and is dedicated to helping agencies achieve success throughout the remainder of 2023 and beyond.

View a copy of the official OASIS-E Manual here.

###

About DecisionHealth

DecisionHealth, an HCPro brand, is the industry’s leading source for home health agencies and medical practice facilities to receive the latest news, analysis, and regulatory guidance on Medicare coding, OASIS-E changes, reimbursement, benchmarks, payments, and audit compliance through its flagship publications, as well as a wide selection of coding books, educational events, and online tools. Visit http://www.decisionhealth.com.

About HCPro

For over 34 years, HCPro, a division of Simplify Compliance LLC, has specialized in providing the latest healthcare regulatory information through industry-leading publications, continuing education, online coding platforms, instructor-led training, events, consulting services, and more to deliver consistent training, achieve compliance, and maximize workflow efficiencies, resulting in measurable performance and financial improvements. Visit http://www.hcpro.com/.

Share article on social media or email:

New Nectr Nootropic Energy Pouches, Powered by Cognizin®, Offer a Novel Way to Stay Alert and Focused


Nootropic Energy Pouches

Nectr delivers everything health-conscious consumers look for in an energy product without over-consuming energy drinks. The pouch is discreet and convenient and can be used during any activity at any time. Plus, the mouth is where absorption begins!

Nectr Energy recently launched their Nectr Nootropics mouth pouches featuring Cognizin® Citicoline. Focused on the energy pouch sector, the brand decided to introduce this innovative delivery system coupled with a key ingredient that was backed by research.

“Our goal was to come out of the gate with something unique that would create a buzz,” commented Jared Martin, Nectr Co-Founder. “Our inspiration came from a visit to Sweden, where we were exposed to oral pouches. The lightbulb went on immediately, realizing that this was the novel delivery system we had been looking for.” Nectr delivers everything health-conscious consumers look for in an energy product without over-consuming energy drinks. The pouch is discreet and convenient and can be used during any activity at any time. Plus, the mouth is where absorption begins!

“Cognizin® was a clear standout and an ingredient we knew we needed to include in our product not only because it is a trusted source in the industry, but it also has the research to back its function in areas that were important for our brand,” added Jared Martin.

Cognizin® supports brain energy by providing the brain with potent nutrition to keep it functioning at its best by supplying an important cellular building block essential to healthy brain function. The 250 mg per serving of Cognizin® in each pouch boosts brain health, attention, and focus.

Every can of Nectr comes with 16 pouches, equal to four daily servings. A roll has five cans, a total of 80 pouches, or a 20-day supply. It comes in four great flavors Berry Blast, Pure Passion, Iced Mango and Fresh Mint.

“We are excited to have Cognizin® Citicoline featured as a key ingredient in Nectr Nootropic Energy Pouches,” says Karen Todd, MBA, RD, Vice President of Global Brand Marketing, Kyowa Hakko USA, Inc. “The brand has taken a novel approach in the energy sector, opening a whole new audience demographic. Functionality combined with convenience and great flavor – everything healthy lifestyle consumers are looking for.”

To learn more about Cognizin® Citicoline, please visit: https://cognizin.com

To purchase Nectr Nootropic Pouches, please visit: https://www.nectr.energy

About Cognizin® Citicoline:

Cognizin® Citicoline, manufactured by Kyowa Hakko Bio Co., Ltd., is a clinically studied and branded form of Citicoline, a natural substance made endogenously in the body and especially vital to brain health. Citicoline is a potent brain-health nutrient. A proprietary form of citicoline, Cognizin® has been clinically studied to support mental energy, focus, attention, and recall. Cognizin® is manufactured through a fermentation process to yield high quality and high purity. Cognizin® is also highly stable, GRAS, ultra-pure, and allergen-free. For more information on Cognizin®, visit Cognizin.com.

About Kyowa Hakko USA:

Kyowa Hakko USA is the North & South American office of Kyowa Hakko Bio Co. Ltd., an international health ingredients manufacturer and world leader in the development, manufacturing, and marketing of pharmaceuticals, nutraceuticals, and food & beverage products. Kyowa is the maker of branded ingredients, including IMMUSE™ LC-Plasma, Eyemuse™ Lacticaseibacillus paracasei KW3110, Cognizin® Citicoline, Pantesin® Pantethine, Setria® Glutathione, as well as L-Alanyl-L-Glutamine. For more information, visit http://www.kyowa-usa.com.

Media Contacts:

Giselle Chollett

giselle@adinnyc.com

917.386.7116.

Share article on social media or email:

GO Topeka’s Plug and Play Animal Health Accelerator Announces Bimini Pet Health as New Corporate Partner


Plug and Play Topeka, a global innovation platform that creates industry-specific accelerator programs, has selected Bimini Pet Health as its newest corporate partner.

“We are excited to announce our new partnership with Bimini Pet Health. By combining our expertise, we aim to push boundaries and develop cutting-edge solutions that bring value to the animal health ecosystem,” said Lindsay Lebahn, senior program manager for Plug and Play Topeka.

Plug and Play Topeka, a global innovation platform that creates industry-specific accelerator programs, has selected Bimini Pet Health as its newest corporate partner. Bimini Pet Health is a Topeka-based manufacturer of pet health supplements and treats. The partnership will aim to research and develop new technologies to expand the product offerings to deliver a variety of highly differentiated options. Bimini Pet Health joins Plug and Play Topeka as the program’s fourth corporate partner, alongside existing founding partners Cargill, Evergy and Hill’s Pet Nutrition.

“Bimini is excited to partner with Plug and Play Topeka and continue our long-standing relationship with GO Topeka as we start the next chapter of our journey,” said Dr. Sam Al-Murrani, owner of Bimini. “As a growing animal health company, our focus is to become an innovation leader while bringing more jobs to Topeka and Shawnee County. We look forward to continuing to serve our city and community over the coming years, together with our partners.”

The Plug and Play Topeka accelerator aims to bring global innovation to the Midwest by facilitating opportunities for business development, mentorship programs and proof of concepts between the selected startups and founding partners of the program. Since the start of the program in the spring of 2020, 65 startups have participated, leading to 17 pilot projects/proofs of concept, and there have been two successful partnerships between startups and corporate partners. Each year, the program develops two accelerator groups, each comprised of 10-12 animal health and ag-tech startups, who partake in the three-month-long program.

“We are excited to announce our new partnership with Bimini Pet Health,” said Lindsay Lebahn, senior program manager for Plug and Play Topeka. “By combining our expertise, we aim to push boundaries and develop cutting-edge solutions that bring value to the animal health ecosystem. We look forward to collaborating and driving meaningful progress together.”

Topeka is centrally located within the Kansas City Animal Health Corridor, the world’s largest concentration of animal health companies and related industries. More than 300 animal health companies located between Manhattan, Kansas, and Columbia, Missouri, including four of the top 10 animal health companies in the world, generate 56% of the total animal health, diagnostics and pet food sold globally, totaling $21.5 billion in annual sales.

“It’s exciting to see one of our local entrepreneurs come full circle, from starting up his own business and serving on our local boards to now signing on as a corporate partner of Plug and Play’s Animal Health Vertical here in Topeka,” said Stephanie Moran, GO Topeka’s senior vice president of innovation. “Bimini truly embodies the health of our local startup community, and we look forward to working with this innovator to grow the area’s prominence in the animal health realm.”

Corporations and startups interested in Plug and Play’s Animal Health and AgTech Program in Topeka can apply here: https://www.plugandplaytechcenter.com/join/.

About Plug and Play

Plug and Play is the leading innovation platform, connecting startups, corporations, venture capital firms, universities, and government agencies. Headquartered in Silicon Valley, Plug and Play is present in 35+ locations across five continents. The platform offers corporate innovation programs and helps its corporate partners in every stage of their innovation journeys, from education to execution. It also organizes startup acceleration programs and has built an in-house VC to drive innovation across multiple industries where it has invested in hundreds of successful companies, including Dropbox, Guardant Health, Honey, Lending Club, N26, PayPal, and Rappi. For more information, visit https://www.plugandplaytechcenter.com/.

About GO Topeka

GO Topeka creates county-wide economic success for all companies and citizens through implementation of an aggressive economic development strategy that capitalizes on the unique strengths of the community. GO Topeka operates under the Greater Topeka Partnership and is the leading economic development agency in the area. For more, visit GoTopeka.com.

About Bimini Pet Health

Bimini is a growing American animal health company based in the Animal Health Corridor that develops and manufactures pet health products in soft chew, powder, oil, liquid, baked goods and other forms. The company’s facilities are cGMP certified for human food production (21 CFR part 117), FDA registered and USDA-inspected and approved for export to Canada. Other global markets to follow shortly. Bimini offers private/white label and custom manufacturing opportunities for new entrants into the market and existing companies as well as its trademark and patent pending Bimini’s Best branded products for large retail and export market participants.

Share article on social media or email:

VGXI, Inc. Names James Smith as New Chief Accounting Officer


VGXI CAO - James Smith

We are thrilled to welcome [Jim] to VGXI’s leadership team and are confident that his skills and experience will help drive our continued growth and success.

VGXI Inc., a leading contract development and manufacturing organization (CDMO) for plasmid DNA, is pleased to announce the appointment of Mr. James Smith as its new Chief Accounting Officer (CAO). Mr. Smith brings over 15 years of experience in accounting and leadership positions across a variety of industries and disciplines, including healthcare and manufacturing.

Prior to joining VGXI, Mr. Smith worked in various roles including public accounting, private industry, and independent consulting. He has developed a deep financial understanding and demonstrated a track record of delivering high-quality financial results.

“Jim is an accomplished accounting executive with a wealth of experience, including specialized expertise related to the biotech industry and VGXI’s business operations,” said VGXI’s President and CEO, Young Park. “We are thrilled to welcome him to VGXI’s leadership team and are confident that his skills and experience will help drive our continued growth and success.”

Mr. Smith holds a B.A in Business Administration-Accounting from West Virginia University and currently holds designations for Certified Public Accountant (CPA), Certified Global Management Accountant (CGMA), and Certified Forensic Accountant (CrFA). In his new role at VGXI, Mr. Smith will oversee all of the company’s accounting and financial operations at both its legacy location in The Woodlands, TX, and the new VGXI headquarters and manufacturing facility at Deison Technology Park in Conroe, TX.

ABOUT VGXI, INC.

With over 20 years of experience VGXI, Inc. is a leading provider of plasmid DNA manufacturing and development services. The company has a reputation of success in manufacturing DNA products under cGMP conditions for clinical trials in the US, EU, Asia, Canada, and Australia, and its cGMP and non-GMP products have passed rigorous reviews by several international regulatory agencies. VGXI’s ability to work with unique requirements and create custom manufacturing solutions is based on its patented manufacturing process, flexible cGMP production facility, and highly experienced development team. VGXI, Inc. is a GeneOne company.

To learn more, visit https://www.vgxii.com.

ABOUT GENEONE LIFE SCIENCE

GeneOne Life Science Inc. (“GeneOne” KOSPI: 011000) headquartered in Seoul, South Korea is an international biotechnology company and a leading contract manufacturer of DNA plasmids for use in vaccines, gene therapies, and cell therapies. GeneOne has recently expanded into the manufacture and development of mRNA. GeneOne has maintained a focus on vaccines against emerging infectious diseases to address global needs, including in resource challenged regions. Its small molecule portfolio of immunomodulators address diseases such as prevention of upper respiratory bacterial and viral diseases, and treatment of autoimmune and inflammatory diseases. GeneOne has three products against COVID-19 in clinical development: GLS-5310 DNA vaccine (Phase I/IIa), GLS-1200 nasal spray to prevent COVID-19 infection (Phase II), and GLS-1027 to prevent the inflammation and clinical worsening for those infected with COVID-19 (Phase II).

For more information, visit http://www.genels.com.

CAUTIONARY FACTORS THAT MAY AFFECT FUTURE RESULTS

Materials in this press release contain information that includes or is based upon forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Forward-looking statements relate to expectations or forecasts of future events. These statements can be identified by the fact that they do not relate strictly to historical or current facts. They include words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other words and terms of similar meaning in connection with a discussion of potential future events, circumstances or future operating or financial performance. In particular, these include statements relating to future actions, prospective products or product approvals, future performance or results of current and anticipated products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, and financial results. Any or all of our forward-looking statements here or in other publications may turn out to be incorrect. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining our actual future results. Consequently, no forward-looking statement can be guaranteed, and forward-looking statements may be adversely affected by factors, including general market conditions, competitive product development, product availability, current and future branded and generic competition, federal and state regulations and legislation, manufacturing issues, timing of the elimination of trade buying, patent positions, litigations and investigations. Our actual results may vary materially, and there are no guarantees about the performance or valuation of GeneOne stock. It is also important to read the disclosure notice contained in many of the individual GeneOne documents available on the website, as many contain important information on such cautionary factors as of the date of the individual document. We undertake no obligation to correct or update any forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our reports.

Share article on social media or email:

How Can Patient Retention Tools Benefit Recruitment Teams, Upcoming Webinar Hosted by Xtalks


Learn how to implement effective retention strategies and ultimately increase the success of a clinical trial.

Patient recruitment remains a major challenge in the clinical trial industry. With the increasing complexity of study designs and the competitive landscape, implementing effective patient recruitment strategies is more critical than ever. However, equally important is patient retention, which can significantly impact the success of clinical trials.

In this webinar, the featured speakers will focus on how patient retention tools and strategies are a critical component of any patient recruitment strategy, to both maximize the investment in patient recruitment and minimize the number of patients required for enrollment. The speakers will also explore the ROI generated by patient retention and how it can help streamline the patient recruitment process. They will also look at how patient retention can enhance patient satisfaction and improve trial outcomes.

Attendees can look forward to addressing key questions about patient retention, including: What is its importance in clinical trials? What are the available tools for retaining patients? How can these tools aid in patient recruitment? How can it generate ROI for clinical trials? How can it improve overall trial outcomes?

Join the speakers as they explore the power of patient retention tools and their impact on patient recruitment in clinical trials. Learn how to implement effective retention strategies and ultimately increase the success of a clinical trial.

Join Clare Grace, Chief Patient Officer, Parexel; and Brett Kleger, Chief Executive Officer, Datacubed Health, for the live webinar on Wednesday, May 17, 2023, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit How Can Patient Retention Tools Benefit Recruitment Teams.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Pacific Edge Announces Its Key Activities at the AUA Annual Meeting 2023


Events like AUA provide Pacific Edge the best opportunity to listen to the needs of key opinion leaders and currently practicing urologists in relation to future partnership and product developments for Cxbladder.

Cancer diagnostics company Pacific Edge (NZX, ASX: PEB) today announces its key activities at the 2023 AUA Annual meeting to be held April 28 – May 1 in Chicago, Illinois.

The AUA annual meeting, now in its 118th year, is the largest and most prestigious event on the US and global urological calendar, attracting thousands of urologists, uro-oncologists, researchers, educators, advanced practice providers, and other healthcare professionals from around the world.

Pacific Edge will expand its presence at the AUA this year, anchored by a booth in the main hall through which the team will update customers and attendees on the latest product, industry, and clinical program developments. Over the course of the event, we’ll also be coordinating a range of activities designed to connect with clinicians, key opinion leaders (KOLs), and research partners.

Pacific Edge will sponsor several sessions on Sunday April 30, including a breakfast for the Society of Women in Urology – a key underserved community within urology; a meeting of the Urological Society for American Veterans (USAV) – the VA is a major partner in our clinical evidence generation program and the largest health system in the USA; and a Bladder Cancer Forum hosted by the International Bladder Cancer Group (IBCG). The forum, initiated at AUA 2022, is now an important platform for thought leadership within the AUA, and will feature expert panelists from around the world leading practical, case-based debates that address common problems and dilemmas in the management of bladder cancer. This year the forum will be moderated by Dr. Ashish Kamat and Dr. Roger Li.

Further detail on the sponsored Sunday sessions:

  • 7:30am – 10am Society of Women in Urology (SWIU) Annual Breakfast. Jackson Park Room, Hyatt Regency McCormick Place
  • 10:30am – 2:30pm Urological Society for American Veterans (USAV). Regency Ballroom CDE, Hyatt Regency McCormick Place
  • 2pm – 5pm Bladder Cancer Forum. Vista Room, McCormick Place Convention Center

Pacific Edge will also sponsor a continuing medical education (CME) course, 8am Friday, April 28 at the Convention Center, focused on the treatment and care of patients with non-muscle invasive bladder cancer (NMIBC) during a shortage of BCG, an immunotherapy drug used in the treatment of early-stage bladder cancer.

Pacific Edge’s CEO, Dr. Peter Meintjes says: “Events like AUA provide Pacific Edge the best opportunity to listen to the needs of key opinion leaders and currently practicing urologists in relation to future partnership and product developments for Cxbladder. Reciprocally, it is also our best opportunity to educate the urology community on what has already been achieved with Cxbladder by our clinical trials partners, research collaborators, high-throughput users and advocates. I am delighted by the program we’ve put together and look forward to connecting with as many customers and partners as possible.”

Share article on social media or email:

SafetyStratus Accelerates Reporting Capabilities for Chemical Inventory Users


Whatever the industry, when you work in a facility with hazardous chemicals, both the risk variables and the regulatory requirements can be continuously changing. We don’t want our partner organizations worrying about that.” -Akiladevi Mannarswamy, Product Manager for SafetyStratus.

SafetyStratus, a leading provider of user-friendly, cloud-based software solutions for Environmental, Health, and Safety (EH&S) management, today announced an expansion to its automated regulatory reporting capabilities. The SafetyStratus chemical inventory management module was upgraded to include several new local, state, and federal regulatory reporting templates for the immediate export of data. With this addition, localized and far-ranging user communities can access the extensive SafetyStratus chemical database to generate complex regulatory reports for print, transfer, or sharing with the appropriate authorities.

Many facilities will need to annually submit data for their hazardous chemicals onsite. By utilizing the reporting functionality’s templates to crosscheck database filters such as location (i.e., building, room, bench number, etc.), hazards, quantities, and other inclusion criteria, users can export data for mixtures, thresholds, and concentrations of any of the compounds within their inventory. If quantities within the inventory exceed the limit for a certain report, that compound will be flagged on the file that users receive when they export that data. Recent template additions include state-specific Tier II reports, such as the Hazardous Materials Business Plan (HMBP) Report for California and the New York City Community Right to Know (NYC RTK) Report for New York.

Speaking to the fact that the security of chemicals is not only high-risk but an ongoing issue, SafetyStratus’ Product Manager, Akiladevi Mannarswamy states, “Whatever the industry, when you work in a facility with hazardous chemicals, both the risk variables and the regulatory requirements can be continuously changing. We don’t want our partner organizations worrying about that. That’s why I am proud to be on a team that is playing a role in the digital transformation of database management and recordkeeping. We want to enable safety-centric operations.” As a cloud-based SaaS solution, user communities will have immediate access to module-applicable updates as the SafetyStratus platform continues to expand over time.

To read more about our recent software updates, visit the EHS Spark page.

For inquiries about the SafetyStratus chemical inventory module, or any of our other EH&S management solutions, contact our team here: https://www.safetystratus.com/contact-us/

About SafetyStratus

SafetyStratus is designed by EH&S professionals for EH&S professionals. Our multi-level technology platform brings user-friendly, practical innovation to Environmental, Health, and Safety Management in Academia, Healthcare, Construction, and Manufacturing. Our aim is to always be learning. We save lives and the environment by successfully integrating knowledgeable people, sustainable processes, and transformative technology. SafetyStratus has headquarters located in Plano, TX with an employee base of industry experts and leaders, spanning the globe. We offer 24/7 coverage from our ROI-focused services team equipped with digitally transformative technology applications for clientele support.

For more information visit http://www.safetystratus.com or LinkedIn, Twitter, and Facebook.

Share article on social media or email:



People USA is Adding a Critical Tool to the Mental Health Toolkit


“We look to be an effective partner in helping the Columbia County community. We commend Dan Almasi and his team for embracing the value of Peer Services,” Steve Miccio, Chief Executive Officer, People USA.

People USA is adding a Certified Peer Specialist to Columbia County’s mental health clinic located at 325 Columbia St Hudson, NY 12534. Currently, these clinics have social workers, nurses, and psychiatrists that help children and adults with their mental health challenges. Columbia County has added another tool to its behavioral health toolkit – a Peer.

This Certified Peer Specialist will be provided by People USA and embedded in Columbia County’s mental health clinic. The Peer will add to the existing staff to instill hope, support wellness, and demonstrate that recovery is real and does happen. The Peer will utilize trauma-informed techniques to help participants set goals, engage in social events, and connect with community resources. The Peer will also provide support for participants to divert hospitalization after discharge. Ultimately, the Peer will share personal experiences that encourage mental wellness and recovery.

“The Columbia County Department of Human Services is very excited to partner with People USA in bringing peer services to its community mental health center. Seeking help can be a challenging experience, and having a person with lived experience to assist in the process has proven beneficial when it comes to engagement with behavioral health services,’ Daniel S. Almasi, LCSW-R, Director of Community Services, Columbia County.

People USA and Columbia County are using this project to create a more holistic continuum of care together.

“We look to be an effective partner in helping the Columbia County community. We commend Dan Almasi and his team for embracing the value of Peer Services, “Steve Miccio, Chief Executive Officer, People USA.

People USA’s mission is to educate, support, and empower people and communities to understand, manage, and overcome mental health, addiction, and social determinant of health challenges.

Share article on social media or email:

The Future of Crisis Care Isn’t in a Hospital


“We appreciate the McSilver Institute’s investment in researching non-traditional peer models. We look forward to the next step in building practice-based evidence into an evidence-based practice,” Steve Miccio, Chief Executive Officer, People USA.

People USA’s innovative Crisis Stabilization Center model is being evaluated by The McSilver Institute for Poverty Policy and Research at New York University. People USA has established the first-ever peer-run Crisis Stabilization Center. Given its innovation, the McSilver Institute will be conducting an evaluation to better understand the “secret sauce” that makes the Crisis Stabilization Center successful. Furthermore, this project will evaluate the outcomes the individuals served are experiencing.

Behavioral health crisis has been on the rise since before the pandemic and has only increased since 2020. COVID has shown us the difficulty faced by our healthcare system in managing a large influx of new patients. And with mental health challenges on the rise, when an individual is experiencing a mental health or substance use crisis, their first instinct is to go to the hospital, which further burdens the system. In addition, the hospital is often not the best place for someone experiencing a behavioral health challenge, especially a child who can be further traumatized by the experience (currently, 50% of individuals served at the Crisis Stabilization Center are children). That is why People USA has created and implemented a peer-run Crisis Stabilization Center.

“We are excited to partner with People USA on the evaluation of the Crisis Stabilization Center and its effectiveness in providing individuals experiencing a behavioral health crisis with a peer-operated alternative to a hospital setting,” Andrew F. Cleek, Psy.D., Deputy Executive Director, NYU McSilver Institute.

Peers are individuals with lived experience who have personally overcome mental health or substance use challenges. Peers can have a variety of credentials from Licensed Social Workers, Nurses, Certified Peer Advocates, Credentialed Family Advocates, and more.

The Crisis Stabilization Center is a 24/7 community crisis response hub where people of all ages can connect immediately with an integrated team of clinical counselors, peer specialists, and behavioral health professionals. The Center is 100% voluntary. Individuals use the Stabilization Center when they’re experiencing emotional distress, acute psychiatric symptoms, addiction challenges, intoxication, family issues, and other life stressors. Stabilization Center guests have immediate access to whole health assessments, crisis counseling, guest-centered care planning, recovery & wellness education, direct connections to outside services, advocacy, and follow-up to ensure quality care.

“We appreciate the McSilver Institute’s investment in researching non-traditional peer models. We look forward to the next step in building practice-based evidence into an evidence-based practice,” Steve Miccio, Chief Executive Officer, People USA.

People USA’s mission is to educate, support, and empower people and communities to understand, manage, and overcome mental health, addiction, and social determinant of health challenges.

The McSilver Institute for Poverty Policy and Research at New York University is committed to disrupting generational poverty through research, policy, and action.

Share article on social media or email: